Alamandine protects against renal ischaemia-reperfusion injury in rats via inhibiting oxidative stress

被引:17
作者
Zhu, Jue [1 ]
Qiu, Jian-Guo [2 ]
Xu, Wei-Tao [3 ]
Ma, Hong-Xiang [4 ]
Jiang, Ke [4 ]
机构
[1] Peoples Hosp Liyang, Dept Nephrol, Changzhou, Peoples R China
[2] Nanjing Med Univ, Kangda Coll, Lianshui Peoples Hosp, Dept Urol, Huaian, Peoples R China
[3] Zaozhuang Min Grp Cent Hosp, Dept Nephrol, Zaozhuang, Peoples R China
[4] Peoples Hosp Liyang, Dept Urol, 70 Jianshe West Rd, Changzhou 213399, Jiangsu, Peoples R China
关键词
alamandine; renal ischaemia and reperfusion; inflammation; apoptosis; oxidative stress; NADPH oxidase 1; ISCHEMIA/REPERFUSION INJURY; APOPTOSIS; ANGIOTENSIN-(1-7); INFLAMMATION; AUTOPHAGY; FAILURE; MICE;
D O I
10.1093/jpp/rgab091
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective This study was to determine whether alamandine (Ala) could reduce ischaemia and reperfusion (I/R) injury of kidney in rats. Methods Renal I/R was induced by an occlusion of bilateral renal arteries for 70 min and a 24-h reperfusion in vivo, and rat kidney proximal tubular epithelial cells NRK52E were exposed to 24 h of hypoxia and followed by 3-h reoxygenation (H/R) in vitro. Results The elevated serum creatinine (Cr), blood cystatin C (CysC) and blood urea nitrogen (BUN) levels in I/R rats were inhibited by Ala treatment.Tumour necrosis factor alpha (TNF)-alpha, IL-1 beta, IL-6, cleaved caspase-3, cleaved caspase-8 and Bax were increased, and BcI2 was reduced in the kidney of I/R rats, which were reversed by Ala administration. Ala reversed the increase of TNF-alpha, IL-beta, cleaved caspase-3, cleaved caspase-8 and Bax and the decrease of Bcl2 in the H/R NRK52E cells. Ala could also inhibit the increase of oxidative stress levels in the kidney of I/R rats. NADPH oxidase 1 (Nox1) overexpression reversed the improving effects of Ala on renal function, inflammation and apoptosis of I/R rats. Conclusion These results indicated that Ala could improve renal function, attenuate inflammation and apoptosis in the kidney of I/R rats via inhibiting oxidative stress.
引用
收藏
页码:1491 / 1502
页数:12
相关论文
共 51 条
[31]   Renal ischemia/reperfusion injury; from pathophysiology to treatment [J].
Malek, Maryam ;
Nematbakhsh, Mehdi .
JOURNAL OF RENAL INJURY PREVENTION, 2015, 4 (02) :20-27
[32]   Angiotensin II and renal fibrosis [J].
Mezzano, SA ;
Ruiz-Ortega, M ;
Egido, J .
HYPERTENSION, 2001, 38 (03) :635-638
[33]   Independent regulation of renin-angiotensin-aldosterone system in the kidney [J].
Nishiyama, Akira ;
Kobori, Hiroyuki .
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2018, 22 (06) :1231-1239
[34]  
Qin C, 2017, EXP CELL RES, V359, P138, DOI 10.1016/j.yexcr.2017.07.038
[35]   Angiotensin-(1-7) reduces doxorubicin-induced cardiac dysfunction in male and female Sprague-Dawley rats through antioxidant mechanisms [J].
Rahimi, Omeed ;
Kirby, Jay ;
Varagic, Jasmina ;
Westwood, Brian ;
Tallant, E. Ann ;
Gallagher, Patricia E. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2020, 318 (04) :H883-H894
[36]   Improving the outcome of kidney transplantation by ameliorating renal ischemia reperfusion injury: lost in translation? [J].
Saat, T. C. ;
van den Akker, E. K. ;
IJzermans, J. N. M. ;
Dor, F. J. M. F. ;
de Bruin, R. W. F. .
JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
[37]   The effect of angiotensin 1-7 and losartan on renal ischemic/reperfusion injury in male rats [J].
Safari, Tahereh ;
Shahraki, Mohamad Reza ;
Miri, Saideh ;
Bakhshani, Nasime Mirakzehi ;
Niazi, Abbass Ali ;
Komeili, Gholam Reza ;
Bagheri, Hossain .
RESEARCH IN PHARMACEUTICAL SCIENCES, 2019, 14 (05) :441-447
[38]   Complications of Solid 8 Organ Transplantation Cardiovascular, Neurologic, Renal, and Gastrointestinal [J].
Sen, Ayan ;
Callisen, Hannelisa ;
Libricz, Stacy ;
Patel, Bhavesh .
CRITICAL CARE CLINICS, 2019, 35 (01) :169-+
[39]   Angiotensin II type 2 receptor and angiotensin-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic rats [J].
Sharma, Nisha ;
Malek, Vajir ;
Mulay, Shrikant R. ;
Gaikwad, Anil Bhanudas .
LIFE SCIENCES, 2019, 235
[40]  
Shen Y, 2018, EUR REV MED PHARMACO, V22, P2134, DOI 10.26355/eurrev_201804_14747